PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930134
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930134
C-Reactive Protein Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of C-reactive protein (CRP) testing Market
The global C-reactive protein (CRP) testing market is projected to witness steady growth due to the rising prevalence of chronic diseases, increasing adoption of point-of-care (POC) testing, and growing awareness about the role of CRP as an inflammation marker. According to Fortune Business Insights, the market was valued at USD 2.55 billion in 2025, expected to grow to USD 2.69 billion in 2026, and is forecasted to reach USD 3.95 billion by 2034, registering a CAGR of 4.9% during the forecast period. North America dominated the market in 2025 with a share of 34.5%, driven by high disease burden, advanced healthcare infrastructure, and growing preference for CRP point-of-care tests.
CRP is a non-specific marker of inflammation and plays a critical role in predicting cardiovascular risks, including heart attack and stroke. It is also used in diagnosing chronic conditions such as cancer, rheumatoid arthritis, and other autoimmune diseases. The market growth is further supported by technological advancements in CRP testing instruments and kits, including POC solutions.
Market Dynamics
Drivers
The increasing prevalence of chronic diseases, such as cardiovascular diseases, cancer, and autoimmune disorders, has driven the demand for CRP testing. According to CDC data from 2022, approximately 20.1 million adults in the U.S. suffer from coronary artery disease, with an estimated 805,000 heart attacks occurring annually. The rising patient population and growing focus on preventive healthcare have fueled the adoption of CRP testing globally.
Another major driver is the development of point-of-care CRP tests, which aid clinicians in reducing antibiotic prescriptions and improving diagnostic efficiency. For instance, research published in the British Journal of General Practice (2022) highlighted the use of CRP POC testing for acute respiratory infections to minimize unnecessary antibiotic use. Companies such as Bloom Diagnostics and LumiraDx are launching advanced POC CRP tests to address this growing need.
Trends
The market is witnessing a growing focus on technologically advanced testing kits and instruments. The immunoturbidimetric assay segment dominated the market in 2026 with a 75.09% share, due to widespread product availability and strong adoption in clinical laboratories. High-sensitivity CRP (hs-CRP) testing is gaining traction for cardiovascular risk assessment. Additionally, the increasing use of POC tests in community healthcare settings is expected to drive growth further.
Restraints
CRP is a non-specific inflammation marker, which limits its use as a standalone diagnostic test. Alternative diagnostics, such as coronary CT angiography, electrocardiography (ECG), and stress tests, provide more accurate disease-specific results. The availability of these alternatives may slow the adoption of CRP tests to some extent.
Market Segmentation
By Product: The market is divided into reagents & kits and instruments. Reagents & kits dominated with a 73.61% share in 2026, driven by high testing volumes and strong offerings from key players like Abbott and LumiraDx. The instruments segment is expected to grow due to increasing regulatory approvals for innovative devices, such as the ProciseDx instrument approved by the U.S. FDA in 2022.
By Assay Type: The market is segmented into immunoturbidimetric assay, ELISA, CLIA, and others. Immunoturbidimetric assays lead due to ease of use and widespread adoption, while ELISA and CLIA-based assays are steadily growing, particularly for chronic disease detection.
By Detection Range: Conventional CRP dominated with an 89.96% share in 2026, primarily for chronic and autoimmune disease monitoring. High-sensitivity CRP tests are increasingly used for cardiovascular risk assessment.
By Setting: Laboratory testing led with 75.84% share in 2026, attributed to precise and comprehensive analysis. POC testing is expected to grow significantly in resource-limited or primary care settings.
By End-User: Diagnostic laboratories dominate due to the increasing number of tests for chronic disease management, while hospitals and clinics are expected to witness strong growth due to rising hospitalizations and clinical demand.
Regional Insights
- North America: USD 0.88B (2025), USD 0.85B (2026); dominated by U.S. chronic disease burden, innovation, and clinical research.
- Europe: UK USD 0.12B, Germany USD 0.18B (2026); growth supported by regulatory approvals, CE-marked products, and rising adoption for autoimmune disease monitoring.
- Asia Pacific: Japan USD 0.15B, China USD 0.22B, India USD 0.11B (2026); driven by chronic disease prevalence, public health initiatives, and strategic partnerships such as FIND-SD Biosensor collaborations.
- Latin America & Middle East/Africa: Moderate growth due to improving healthcare infrastructure and adoption of rapid diagnostic tests.
Key Industry Players
Prominent companies in the market include Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Merck KGaA, Getein Biotech, Randox Laboratories, Boditech Med, and LumiraDx. Market players are focusing on research and development, new product launches, and expanding POC offerings. For instance, Abbott's acquisition of Alere Inc. in 2016 expanded its POC testing portfolio.
Notable developments include Siemens FDA clearance for CardioPhase hs-CRP test (Dec 2022) and Boditech Med MoU for North American market entry (Mar 2022).
Conclusion
The global C-reactive protein testing market is projected to grow from USD 2.55 billion in 2025 to USD 3.95 billion by 2034, supported by rising chronic disease prevalence, increasing adoption of POC tests, and continuous innovation in assay technologies. Despite limitations due to alternative diagnostics, CRP testing remains a vital tool for inflammation monitoring, cardiovascular risk prediction, and improving patient management worldwide.
Segmentation By Product, Assay Type, Detection Range, Setting, End User, and Region
By Product * Reagents & Kits
- Instruments
By Assay Type * Chemiluminescence Immunoassay (CLIA)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunoturbidimetric Assay
- Others
By Detection Range * Conventional CRP
- hs-CRP
By Setting
Laboratory Testing
- Point-of-Care (POC) Testing
By End User * Hospitals & Clinics
- Diagnostic Laboratories
- Others
By Region * North America (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country)
- U.S.
- Canada
- Europe (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Chronic Diseases, By Key Countries/Regions
- 4.2. Technological Advancements in C-Reactive Protein Testing
- 4.3. New Product Launches
- 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
- 4.5. Impact of COVID-19 on the Market
5. Global C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Reagents & Kits
- 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast - By Assay Type
- 5.2.1. Chemiluminescence Immunoassay (CLIA)
- 5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 5.2.3. Immunoturbidimetric Assay
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Detection Range
- 5.3.1. Conventional CRP
- 5.3.2. Hs-CRP
- 5.4. Market Analysis, Insights and Forecast - By Setting
- 5.4.1. Laboratory Testing
- 5.4.2. Point-of-Care (POC) Testing
- 5.5. Market Analysis, Insights and Forecast - By End-User
- 5.5.1. Hospitals & Clinics
- 5.5.2. Diagnostic Laboratories
- 5.5.3. Others
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Reagents & Kits
- 6.1.2. Instruments
- 6.2. Market Analysis, Insights and Forecast - By Assay Type
- 6.2.1. Chemiluminescence Immunoassay (CLIA)
- 6.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 6.2.3. Immunoturbidimetric Assay
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Detection Range
- 6.3.1. Conventional CRP
- 6.3.2. Hs-CRP
- 6.4. Market Analysis, Insights and Forecast - By Setting
- 6.4.1. Laboratory Testing
- 6.4.2. Point-of-Care (POC) Testing
- 6.5. Market Analysis, Insights and Forecast - By End-User
- 6.5.1. Hospitals & Clinics
- 6.5.2. Diagnostic Laboratories
- 6.5.3. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Reagents & Kits
- 7.1.2. Instruments
- 7.2. Market Analysis, Insights and Forecast - By Assay Type
- 7.2.1. Chemiluminescence Immunoassay (CLIA)
- 7.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 7.2.3. Immunoturbidimetric Assay
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Detection Range
- 7.3.1. Conventional CRP
- 7.3.2. Hs-CRP
- 7.4. Market Analysis, Insights and Forecast - By Setting
- 7.4.1. Laboratory Testing
- 7.4.2. Point-of-Care (POC) Testing
- 7.5. Market Analysis, Insights and Forecast - By End-User
- 7.5.1. Hospitals & Clinics
- 7.5.2. Diagnostic Laboratories
- 7.5.3. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Rest of Europe
8. Asia Pacific C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Reagents & Kits
- 8.1.2. Instruments
- 8.2. Market Analysis, Insights and Forecast - By Assay Type
- 8.2.1. Chemiluminescence Immunoassay (CLIA)
- 8.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 8.2.3. Immunoturbidimetric Assay
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Detection Range
- 8.3.1. Conventional CRP
- 8.3.2. Hs-CRP
- 8.4. Market Analysis, Insights and Forecast - By Setting
- 8.4.1. Laboratory Testing
- 8.4.2. Point-of-Care (POC) Testing
- 8.5. Market Analysis, Insights and Forecast - By End-User
- 8.5.1. Hospitals & Clinics
- 8.5.2. Diagnostic Laboratories
- 8.5.3. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. Australia
- 8.6.5. Rest of Asia Pacific
9. Latin America C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Reagents & Kits
- 9.1.2. Instruments
- 9.2. Market Analysis, Insights and Forecast - By Assay Type
- 9.2.1. Chemiluminescence Immunoassay (CLIA)
- 9.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 9.2.3. Immunoturbidimetric Assay
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Detection Range
- 9.3.1. Conventional CRP
- 9.3.2. Hs-CRP
- 9.4. Market Analysis, Insights and Forecast - By Setting
- 9.4.1. Laboratory Testing
- 9.4.2. Point-of-Care (POC) Testing
- 9.5. Market Analysis, Insights and Forecast - By End-User
- 9.5.1. Hospitals & Clinics
- 9.5.2. Diagnostic Laboratories
- 9.5.3. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
10. Middle East & Africa C-Reactive Protein Testing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Reagents & Kits
- 10.1.2. Instruments
- 10.2. Market Analysis, Insights and Forecast - By Assay Type
- 10.2.1. Chemiluminescence Immunoassay (CLIA)
- 10.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 10.2.3. Immunoturbidimetric Assay
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Detection Range
- 10.3.1. Conventional CRP
- 10.3.2. Hs-CRP
- 10.4. Market Analysis, Insights and Forecast - By Setting
- 10.4.1. Laboratory Testing
- 10.4.2. Point-of-Care (POC) Testing
- 10.5. Market Analysis, Insights and Forecast - By End-User
- 10.5.1. Hospitals & Clinics
- 10.5.2. Diagnostic Laboratories
- 10.5.3. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. GCC
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
- 11.2.1. Abbott
- 11.2.1.1. Overview,
- 11.2.1.2. Product,
- 11.2.1.3. SWOT Analysis,
- 11.2.1.4. Recent Developments,
- 11.2.1.5. Strategies,
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. F. Hoffmann-La Roche Ltd.
- 11.2.2.1. Overview,
- 11.2.2.2. Product,
- 11.2.2.3. SWOT Analysis,
- 11.2.2.4. Recent Developments,
- 11.2.2.5. Strategies,
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Siemens Healthcare Private Limited
- 11.2.3.1. Overview,
- 11.2.3.2. Product,
- 11.2.3.3. SWOT Analysis,
- 11.2.3.4. Recent Developments,
- 11.2.3.5. Strategies,
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. Quest Diagnostics Incorporated
- 11.2.4.1. Overview,
- 11.2.4.2. Product,
- 11.2.4.3. SWOT Analysis,
- 11.2.4.4. Recent Developments,
- 11.2.4.5. Strategies,
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Thermo Fisher Scientific, Inc.
- 11.2.5.1. Overview,
- 11.2.5.2. Product,
- 11.2.5.3. SWOT Analysis,
- 11.2.5.4. Recent Developments,
- 11.2.5.5. Strategies,
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. Merck KGaA
- 11.2.6.1. Overview,
- 11.2.6.2. Product,
- 11.2.6.3. SWOT Analysis,
- 11.2.6.4. Recent Developments,
- 11.2.6.5. Strategies,
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. Getein Biotech, Inc.
- 11.2.7.1. Overview,
- 11.2.7.2. Product,
- 11.2.7.3. SWOT Analysis,
- 11.2.7.4. Recent Developments,
- 11.2.7.5. Strategies,
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. Randox Laboratories Ltd.
- 11.2.8.1. Overview,
- 11.2.8.2. Product,
- 11.2.8.3. SWOT Analysis,
- 11.2.8.4. Recent Developments,
- 11.2.8.5. Strategies,
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. BODITECH MED, INC.
- 11.2.9.1. Overview,
- 11.2.9.2. Product,
- 11.2.9.3. SWOT Analysis,
- 11.2.9.4. Recent Developments,
- 11.2.9.5. Strategies,
- 11.2.9.6. financials (Based on Availability)
- 11.2.10. LumiraDx
- 11.2.10.1. Overview,
- 11.2.10.2. Product,
- 11.2.10.3. SWOT Analysis,
- 11.2.10.4. Recent Developments,
- 11.2.10.5. Strategies,
- 11.2.10.6. financials (Based on Availability)
- 11.2.1. Abbott
List of Tables
- Table 1: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 3: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 4: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 5: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 6: Global C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 7: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 8: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 9: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 10: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 11: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 12: North America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 14: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 15: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 16: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 17: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 18: Europe C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 19: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 20: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 21: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 22: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 23: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 24: Asia Pacific C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 25: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 26: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 27: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 28: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 29: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 30: Latin America C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 32: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Assay Type, 2021-2034
- Table 33: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Detection Range, 2021-2034
- Table 34: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by Setting, 2021-2034
- Table 35: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, by End-User, 2021-2034
- Table 36: Middle East & Africa C-Reactive Protein Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global C-Reactive Protein Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global C-Reactive Protein Testing Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025 & 2034
- Figure 4: Global C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025 & 2034
- Figure 5: Global C-Reactive Protein Testing Market Value Share (%), by Setting, 2025 & 2034
- Figure 6: Global C-Reactive Protein Testing Market Value Share (%), by End-User, 2025 & 2034
- Figure 7: Global C-Reactive Protein Testing Market Value (USD billion), by Region, 2025 & 2034
- Figure 8: North America C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034
- Figure 9: North America C-Reactive Protein Testing Market Value Share (%), by Product, 2025
- Figure 10: North America C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034
- Figure 11: North America C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025
- Figure 12: North America C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034
- Figure 13: North America C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025
- Figure 14: North America C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 15: North America C-Reactive Protein Testing Market Value Share (%), by Setting, 2025
- Figure 16: North America C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034
- Figure 17: North America C-Reactive Protein Testing Market Value Share (%), by End-User, 2025
- Figure 18: North America C-Reactive Protein Testing Market Value (USD billion), By Country, 2025 & 2034
- Figure 19: North America C-Reactive Protein Testing Market Value Share (%), By Country, 2025
- Figure 20: Europe C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034
- Figure 21: Europe C-Reactive Protein Testing Market Value Share (%), by Product, 2025
- Figure 22: Europe C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034
- Figure 23: Europe C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025
- Figure 24: Europe C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034
- Figure 25: Europe C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025
- Figure 26: Europe C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 27: Europe C-Reactive Protein Testing Market Value Share (%), by Setting, 2025
- Figure 28: Europe C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034
- Figure 29: Europe C-Reactive Protein Testing Market Value Share (%), by End-User, 2025
- Figure 30: Europe C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 31: Europe C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 32: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034
- Figure 33: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Product, 2025
- Figure 34: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034
- Figure 35: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025
- Figure 36: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034
- Figure 37: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025
- Figure 38: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 39: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by Setting, 2025
- Figure 40: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034
- Figure 41: Asia Pacific C-Reactive Protein Testing Market Value Share (%), by End-User, 2025
- Figure 42: Asia Pacific C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 43: Asia Pacific C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 44: Latin America C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034
- Figure 45: Latin America C-Reactive Protein Testing Market Value Share (%), by Product, 2025
- Figure 46: Latin America C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034
- Figure 47: Latin America C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025
- Figure 48: Latin America C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034
- Figure 49: Latin America C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025
- Figure 50: Latin America C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 51: Latin America C-Reactive Protein Testing Market Value Share (%), by Setting, 2025
- Figure 52: Latin America C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034
- Figure 53: Latin America C-Reactive Protein Testing Market Value Share (%), by End-User, 2025
- Figure 54: Latin America C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 55: Latin America C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 56: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Product, 2025 & 2034
- Figure 57: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Product, 2025
- Figure 58: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Assay Type, 2025 & 2034
- Figure 59: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Assay Type, 2025
- Figure 60: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Detection Range, 2025 & 2034
- Figure 61: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Detection Range, 2025
- Figure 62: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 63: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by Setting, 2025
- Figure 64: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), by End-User, 2025 & 2034
- Figure 65: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), by End-User, 2025
- Figure 66: Middle East & Africa C-Reactive Protein Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 67: Middle East & Africa C-Reactive Protein Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 68: Global C-Reactive Protein Testing Market Share (%), By Company, 2025
